Creotech Instruments (CRI) Q3 2025 earnings summary

Executive summary

• Revenue for the nine months ended September 30, 2025, reached 95.1 million PLN, up by 72.1 million PLN year-over-year, mainly due to progress in the “Mikroglob” project.

• Net loss from continuing operations was -3.0 million PLN, a significant improvement from -14.5 million PLN in the prior year period.

• The company expanded its capital group by establishing two subsidiaries: Creotech Quantum S.A. and Creotech Geo P.S.A.

• Major contracts were signed with the European Space Agency and the Polish government, including the “Mikroglob” and “CAMILA” satellite projects.

Financial highlights

• Operating loss for the period was -4.7 million PLN, compared to -17.2 million PLN a year earlier.

• Cash flow from operating activities was 25.8 million PLN, versus -5.1 million PLN in the prior year.

• Total assets as of September 30, 2025, were 317.0 million PLN, up from 162.3 million PLN at year-end 2024.

• Equity increased to 140.7 million PLN, up by 69.8 million PLN from December 2024, mainly due to a new share issue.

• Cash and equivalents at period end were 108.1 million PLN, up from 32.4 million PLN at the end of 2024.

Outlook and guidance

• Future results depend on the timing of milestone completions in large contracts, especially “Mikroglob.”

• The company expects continued volatility in sales but no clear seasonality due to diversified operations and long-term projects.

• ESA’s budget decisions for 2026-2028 may impact future revenues.